Search by...
-
11JanDoctors and the use of social media and electronic communication systems: The new FNOMCeO recommendationsFNOMCeO presented a set of Recommendations for the use of social media, e-mail, and instant messaging in the medical setting and in physician-patient communication, to prevent the potential negative repercussions of improper use of these tools.
-
-
22DecArtificial intelligence and health care: News and issues in light of guidance from the Italian Data Protection Authority and the WHOThe use of AI in the healthcare field raises numerous issues. AI is promising and could facilitate improvement of treatment and prevention, and result in more effective allocation of resources in the field. However, there is trepidation about the consequences of possible errors and incorrect use.
-
-
14DecThe Lawyer European Awards 2023: Portolano Cavallo named European Litigation Team of the YearPortolano Cavallo was named “European Litigation Team of the Year” by the British magazine The Lawyer at its European Awards 2023.Article filed under: Dispute Resolution
-
14NovPortolano Cavallo: Alessandro Tanno joins as of counsel to lead Banking & Finance practicePortolano Cavallo strengthens its Banking & Finance practice by welcoming Alessandro Tanno, continuing on the path set by expanding Private EquityArticle filed under: Banking & Finance
-
23OctThe digital caregiver: Insights from the 4th AFI Patient DayCon il termine caregiver si intende una persona che presta assistenza quotidiana a chi non è autosufficiente. Può trattarsi, a seconda dei casi, di un familiare del paziente o di una persona retribuita (il/la cosiddetto/a badante).
-
-
23OctDrug advertising: New rules on advertising for over-the-counter and non-prescription medicines (OTC and SOP)The Italian Ministry of Health updated the guidelines regulating the use of media to publish advertising messages regarding OTC and SOP: a good step in terms of streamlining and simplification of the applicable regulatory framework. Thanks to Denise Moretti for collaborating on this article
-
-
28SepSunshine Act: Draft Decree for the Sanità Trasparente electronic register publishedNow available the draft decree and technical specifications envisaged by the Sunshine Act, establishing the structure and technical characteristics of the “Sanità Trasparente” electronic register, and the modalities for manufacturing companies to transmit notifications.
-
-
15SepAI and machine learning in the medicine lifecycle: EMA publishes first draft of reflection paperThe first draft of EMA’s “Reflection paper” contains the authority’s latest considerations on the application of AI and machine learning methods in each phase of the medicinal product lifecycle.
-
-
27JulWhistleblowing Decree: Key points for the pharmaceutical sectorLarge multinational companies are being called to assess the compatibility of existing reporting channels with the requirements of the new regulation published on March 15, 2023 on the Official Journal of the Italian Republic, implementing the EU Directive 2019/1937 on whistleblowing.
-
-
11JulPortolano Cavallo announces the appointment of Enzo Marasà as partnerWith Enzo Marasà's appointment, the number of partners rises to 20, showcasing the firm's strong and consistent expansionArticle filed under: EU and Competition Law
